These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9088593)

  • 1. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler.
    Hindle M; Peers EM; Parry-Billings M; Chrystyn H
    Br J Clin Pharmacol; 1997 Mar; 43(3):336-8. PubMed ID: 9088593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser.
    Silkstone VL; Corlett SA; Chrystyn H
    Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.
    Silkstone VL; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2002 Aug; 54(2):115-9. PubMed ID: 12207629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.
    Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design.
    Ammari WG; Oriquat GA; Sanders M
    Eur J Pharm Sci; 2020 Apr; 147():105304. PubMed ID: 32165316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
    Hindle M; Chrystyn H
    Thorax; 1994 Jun; 49(6):549-53. PubMed ID: 8016791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronization.
    Richardson CH; de Matas M; Hosker H; Mukherjee R; Wong I; Chrystyn H
    Pharm Res; 2007 Nov; 24(11):2008-17. PubMed ID: 17510755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumatic usage: some generic salbutamol metered dose inhalers can be used.
    Chege JK; Chrystyn H
    Thorax; 1994 Nov; 49(11):1162-3. PubMed ID: 7831635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.
    Du XL; Zhu Z; Fu Q; Li DK; Xu WB
    Acta Pharmacol Sin; 2002 Jul; 23(7):663-6. PubMed ID: 12100764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the relative bioavailability of salbutamol to the lung following inhalation.
    Hindle M; Chrystyn H
    Br J Clin Pharmacol; 1992 Oct; 34(4):311-5. PubMed ID: 1457264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Hajiro T; Mishima M; Izumi T
    Respiration; 1999; 66(2):119-23. PubMed ID: 10202314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation.
    Chege JK; Chrystyn H
    Respir Med; 2000 Jan; 94(1):51-6. PubMed ID: 10714479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
    Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.
    Lipworth BJ; Clark DJ
    Br J Clin Pharmacol; 1998 Jul; 46(1):45-8. PubMed ID: 9690948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative Lung and Systemic Bioavailability Along with Oropharyngeal Deposition of Salbutamol Post-Inhalation: A Pharmacokinetic Evaluation of Novel Inhaler Technique Training Gadgets.
    Ammari WG; Sanders M
    J Aerosol Med Pulm Drug Deliv; 2022 Oct; 35(5):278-285. PubMed ID: 35984934
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients.
    Moustafa IOF; Ali MRA; Al Hallag M; Rabea H; Fink JB; Dailey P; Abdelrahim MEA
    Heart Lung; 2017; 46(6):464-467. PubMed ID: 28882385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.
    Hindle M; Newton DA; Chrystyn H
    Thorax; 1993 Jun; 48(6):607-10. PubMed ID: 8346489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.